Bottom line
DLHAX vs IYH: the short answer
DLHAX (Nomura Healthcare Fund) and IYH (iShares U.S. Healthcare ETF) are both mutual funds.
IYH is cheaper at 0.37% vs 1.21% — a difference of $84 a year per $10,000 invested.
Over five years, IYH returned +7.0% a year vs +6.2% for DLHAX.
DLHAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
DLHAX vs IYH side by side
| DLHAX | IYH | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Voya | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.21% | 0.37% |
| Annual cost per $10k | $121 | $37 |
| 10-yr cost on $10k (prospectus) | $2,006 | $468 |
| Max front load | 5.75% | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +15.1% | +13.1% |
| 5-yr return (annualized) | +6.2% | +7.0% |
| 10-yr return (annualized) | +9.5% | +9.4% |
| Best quarter | +21.5% | +15.3% |
| Worst quarter | −14.9% | −12.7% |
| Net assets (fund) | $750.2M | $3.6B |
| Number of holdings | 108 | 103 |
| Portfolio turnover | 4% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | DLHAX | IYH | Difference |
|---|---|---|---|
| 2025 | +22.1% | +13.1% | +9.0% |
| 2024 | +8.5% | +3.1% | +5.4% |
| 2023 | +4.2% | +2.1% | +2.2% |
| 2022 | −1.3% | −4.4% | +3.1% |
| 2021 | −5.3% | +23.4% | −28.7% |
| 2020 | +11.1% | +15.5% | −4.3% |
| 2019 | +31.5% | +20.8% | +10.7% |
| 2018 | −0.8% | +5.9% | −6.7% |
| 2017 | +32.0% | +22.3% | +9.7% |
| 2016 | −4.3% | −2.8% | −1.5% |
Source: Fund prospectus bar charts
Holdings overlap
11 of DLHAX's top 25 holdings also appear in IYH's top 25.
| Holding | DLHAX | IYH |
|---|---|---|
| Abbvie Inc | 4.19% | 7.32% |
| Eli Lilly & Company | 4.16% | 15.11% |
| Regeneron Pharmaceuticals Inc | 3.91% | 1.27% |
| Unitedhealth Group Inc | 3.88% | 6.16% |
| Pfizer Inc | 3.84% | 2.35% |
| Merck & Company Inc | 3.68% | 5.31% |
| Gilead Sciences Inc | 3.54% | 2.66% |
| Elevance Health Inc | 3.25% | 1.34% |
| Amgen Inc | 2.27% | 3.42% |
| Vertex Pharmaceuticals Inc | 1.66% | 2.00% |
| Boston Scientific Corp | 1.42% | 1.14% |
Source: SEC Form N-PORT
DLHAX top 10
- Ucb Sa — 5.19%
- Abbvie Inc — 4.19%
- Eli Lilly & Company — 4.16%
- Regeneron Pharmaceuticals Inc — 3.91%
- Unitedhealth Group Inc — 3.88%
- Pfizer Inc — 3.84%
- Merck & Company Inc — 3.68%
- Gilead Sciences Inc — 3.54%
- Astrazeneca Plc — 3.27%
- Elevance Health Inc — 3.25%
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
FAQ
What is the difference between DLHAX and IYH?
Which is cheaper, DLHAX or IYH?
Should I own both DLHAX and IYH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.